Hikma Pharmaceuticals (LSE:HIK) Price-to-Operating-Cash-Flow : 7.37 (As of Apr. 30, 2024)

View and export this data going back to 2005. Start your Free Trial

What is Hikma Pharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2024-04-30), Hikma Pharmaceuticals's share price is £19.30. Hikma Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £2.62. Hence, Hikma Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is 7.37.

The historical rank and industry rank for Hikma Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

LSE:HIK' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.81 Med: 14.52 Max: 21.66
Current: 7.43

During the past 13 years, Hikma Pharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 21.66. The lowest was 5.81. And the median was 14.52.

LSE:HIK's Price-to-Operating-Cash-Flow is ranked better than
82.99% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.665 vs LSE:HIK: 7.43

Hikma Pharmaceuticals's Cash Flow from Operations per share for the six months ended in Dec. 2023 was £1.83. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £2.62.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Hikma Pharmaceuticals was 22.60% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 21.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 13.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 8.40% per year.

During the past 13 years, Hikma Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 56.90% per year. The lowest was -1.10% per year. And the median was 19.60% per year.

Hikma Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Hikma Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals Price-to-Operating-Cash-Flow Chart

Hikma Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

13.43

17.37

10.78

7.27

6.83

Hikma Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															10.78	-	7.27	-	6.83

Competitive Comparison of Hikma Pharmaceuticals's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Hikma Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hikma Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hikma Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hikma Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Hikma Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

Hikma Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	19.30	/	2.619
	=	7.37

Hikma Pharmaceuticals's Share Price of today is £19.30.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hikma Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £2.62.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Hikma Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Hikma Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Hikma Pharmaceuticals (LSE:HIK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (LSE:HIK) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

HKMPY:USA HKMPF:USA HIKl:UK H5P:Germany

Address

1 New Burlington Place, London, GBR, W1S 2HR

Website

https://www.hikma.com

Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.

Hikma Pharmaceuticals (LSE:HIK) Headlines

No Headlines